Latest News, Stock Analysis
Tell me something good, Kyverna Therapeutics announce positive SPS trial data Kyverna Therapeutics (NASDAQ: KYTX) stock surged 14% Monday after the company announced positive topline data from its registrational Phase 2 trial of mivocabtagene autoleucel (miv-cel) in...
Latest News, Political News
Having second thoughts, President Trump looks to reclassify Cannabis Cannabis stocks surged Friday after reports that President Donald Trump is considering directing his administration to reclassify marijuana as a less dangerous drug, potentially marking a...